ADME Study of [14C]-Jaktinib in Healthy Male Subjects

NCT05150717 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Adult Male Volunteers

Interventions

DRUG: [14C]-Jaktinib

Sponsor

Suzhou Zelgen Biopharmaceuticals Co.,Ltd